These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9845813)

  • 1. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.
    Qureshi SA; McGilveray IJ
    Eur J Pharm Sci; 1999 Feb; 7(3):249-58. PubMed ID: 9845813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cause of high variability in drug dissolution testing and its impact on setting tolerances.
    Qureshi SA; Shabnam J
    Eur J Pharm Sci; 2001 Jan; 12(3):271-6. PubMed ID: 11113646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic error associated with apparatus 2 of the USP dissolution test III: limitations of calibrators and the USP suitability test.
    Cox DC; Furman WB; Thornton LK; Moore TW; Jefferson EH
    J Pharm Sci; 1983 Aug; 72(8):910-3. PubMed ID: 6620145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
    Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
    Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A better dissolution method for ranitidine tablets USP.
    Cappola ML
    Pharm Dev Technol; 2001; 6(1):11-7. PubMed ID: 11247270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The USP Performance Verification Test, Part II: collaborative study of USP's Lot P Prednisone Tablets.
    Glasgow M; Dressman S; Brown W; Foster T; Schuber S; Manning RG; Wahab SZ; Williams RL; Hauck WW
    Pharm Res; 2008 May; 25(5):1110-5. PubMed ID: 18172582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution testing of acetylsalicylic acid by a channel flow method-correlation to USP basket and intrinsic dissolution methods.
    Peltonen L; Liljeroth P; Heikkilä T; Kontturi K; Hirvonen J
    Eur J Pharm Sci; 2003 Aug; 19(5):395-401. PubMed ID: 12907290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.
    Zhang Y; Bredael G; Armenante PM
    J Pharm Sci; 2013 Aug; 102(8):2718-29. PubMed ID: 23861178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved drug dissolution and product characterization using a crescent-shaped spindle.
    Qureshi SA
    J Pharm Pharmacol; 2004 Sep; 56(9):1135-41. PubMed ID: 15324482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typical variability and evaluation of sources of variability in drug dissolution testing.
    Siewert M; Weinandy L; Whiteman D; Judkins C
    Eur J Pharm Biopharm; 2002 Jan; 53(1):9-14. PubMed ID: 11777747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Approach for the Application of USP Apparatus 3 in Dissolution Tests: Case Studies of Three Antihypertensive Immediate-Release Tablets.
    Espíndola B; Bortolon FF; Pinto JMO; Pezzini BR; Stulzer HK
    AAPS PharmSciTech; 2018 Oct; 19(7):2866-2874. PubMed ID: 29934804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of basket mesh size on the hydrodynamics of a partially filled (500 mL) USP rotating basket dissolution testing Apparatus 1.
    Sirasitthichoke C; Patel S; Reuter KG; Hermans A; Bredael G; Armenante PM
    Int J Pharm; 2024 Jun; 658():124209. PubMed ID: 38718973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative study of the USP dissolution test for prednisone tablets with Apparatus 2.
    Cox DC; Furman WB
    J Pharm Sci; 1984 May; 73(5):670-6. PubMed ID: 6737242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution.
    Röst M; Quist PO
    J Pharm Biomed Anal; 2003 Apr; 31(6):1129-43. PubMed ID: 12667929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-stage sequential statistical dissolution testing rules.
    Tsong Y; Shen M; Shah VP
    J Biopharm Stat; 2004 Aug; 14(3):757-79. PubMed ID: 15468763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shear distribution and variability in the USP Apparatus 2 under turbulent conditions.
    Kukura J; Baxter JL; Muzzio FJ
    Int J Pharm; 2004 Jul; 279(1-2):9-17. PubMed ID: 15234789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of BP and USP rotating basket dissolution apparatus.
    Smith WJ; Heaume PE; Hailey DM; Lea AR
    J Pharm Pharmacol; 1985 Feb; 37(2):124-5. PubMed ID: 2858545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry.
    Ciavarella AB; Khan MA; Gupta A; Faustino PJ
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):523-532. PubMed ID: 27974592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.